Washington Dc, DCNCT07787247Now EnrollingIRB Ready

Myasthenia Gravis (MG) Clinical Trial in Washington Dc, DC

Access cutting-edge myasthenia gravis (mg) treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.

Sponsored by George Washington University

Quick Self-Assessment

See if you qualify for this Washington Dc location

Preparing your pre-screening questions…

Expert Care in Washington Dc

Access myasthenia gravis (mg) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related myasthenia gravis (mg) treatment provided free

Apply for This Washington Dc Location

Check if you qualify for this myasthenia gravis (mg) clinical trial in Washington Dc, DC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Washington Dc

    Convenient for DC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Washington Dc site if eligible
  4. 4Begin participation

About This Myasthenia Gravis (MG) Study in Washington Dc

Myasthenia gravis is an autoimmune neuromuscular disorder characterized by fluctuating weakness, which can worsen suddenly without a clear predictor. The hypothesis is that continuous monitoring of key aspects of patient physiology and activity coupled to rigorous telemedicine-performed examination has the potential to detect MG worsening which requires change in treatment with the benefit of avoiding need for hospitalization or emergent therapy. This study is to evaluate the reliability of the technology and patient compliance to the monitoring program

Sponsor: George Washington University

Who Can Participate

Inclusion Criteria

Has the capacity to understand and sign an informed consent form
≥18 years old
Diagnosed with acquired autoimmune MG based on clinical syndrome and seropositivity for MG associated autoantibodies (AChR binding, MuSK, or LRP4 antibodies), and/or a decremental response on repetitive nerve stimulation, positive single fiber electromyography (EMG) or positive edrophonium test
Subject has been previously evaluated in a face-to-face clinical encounter at participating study site or referral site within the prior 3 years
Primary language is English, or equivalent level of English language fluency
Required disease severity range previously judged by the Investigator. MGFA class 1-4a within 3 years of diagnosis without other chronic medical conditions, which compromise participation.
Having MG-ADL score above 2 upon entrance to study
Patients considered by study PI not to require hospitalization at time of entrance
The patient has internet capability and a smart phone compatible with the apps required by the study.

Exclusion Criteria

Disease Specific Exclusion Criteria
Inability to comply with study protocol for monitoring
Current MGFA Severity Class IVb or V, or patients in remission with MGFA Class 0
Any significant medical/psychiatric condition that, in the opinion of the Investigator, may interfere with interpretation of subject evaluation(s) or protocol compliance
Any disorder that could limit ability to assess myasthenia gravis specific deficits (not including planned or recent thymectomy)
Pregnancy, based on the evaluator's judgment, if the subject is deemed not safe to undergo evaluation or comply with study visit requirements.
Lack of effective internet connection or ability to use study telemedicine station and monitors
Home environment prevents use of study equipment
Likelihood of leaving DC, Maryland, or Virginia area in year after initiation of study
Subject is already participating in a research study -

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Washington Dc?

Yes, this clinical trial (NCT07787247) has an active research site in Washington Dc, DC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Myasthenia Gravis (MG) Treatment Options in Washington Dc, DC

If you're searching for myasthenia gravis (mg) treatment options in Washington Dc, DC, this clinical trial (NCT07787247) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myasthenia gravis (mg) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all myasthenia gravis (mg) clinical trials near you to find additional studies recruiting in your area.

More Myasthenia Gravis Trials in Washington Dc, DC

See all myasthenia gravis clinical trials recruiting in Washington Dc — not just this study.

Browse Myasthenia Gravis Trials in Washington Dc →

Browse More Trials by Condition

Myasthenia Gravis TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Washington Dc?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Washington Dc, DC